HIGHLIGHTS
- who: Moris Angulo from the (UNIVERSITY) have published the article: Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program® and NordiNet® International Outcome Study, in the Journal: (JOURNAL)
- what: This study assessed clinical outcomes based on real-world observational data in pediatric patients with PWS who were treated with GH.
SUMMARY
Genomic imprinting defects cause 3% of cases. The remaining 2% of cases are caused by rare translocations. The overall clinical picture of PWS is characterized by hypotonia, poor feeding in infancy, hyperphagia with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.